University of Wisconsin Testing Antibody Drug on Patients

The drug, an “antibody cocktail” developed by New York-based Regeneron Pharmaceuticals, contains an antibody made by the company and another isolated from recovered COVID-19 patients.

(TNS) - University of Wisconsin Health patients will be among those testing an experimental antibody treatment heavily backed by the federal government to see if it can treat and prevent COVID-19.
 
The drug, an “antibody cocktail” developed by New York-based Regeneron Pharmaceuticals, contains an antibody made by the company and another isolated from recovered COVID-19 patients. About 90 to 150 UW Health patients are expected to join clinical trials of the drug, including patients with the infection and people who don’t have it but live with someone who recently got it.
   ...more



- - Volume: 8 - WEEK: 29 Date: 7/16/2020 9:58:41 AM -